Skip directly to content

HCP & HCO annual Disclosure reports

Working with healthcare professionals (HCPs) and healthcare organisations (HCOs) helps us to deliver better care for patients, and for the HCPs who care for them.
 

By engaging in two-way conversations we can get the most out of our medicines and learn how we can change things to benefit patients.

We provide payments and funding to HCPs for their valuable time and expertise. We also provide funding to HCOs to support patient care or to benefit the NHS, and to organisations for research and development (R&D).

We think it's important the public feels confident our relationships are appropriate and beneficial. That is why we are committed to transparency.

 

Payment Reports

 

A snapshop of the payments made towards UK Research & Development, Healthcare Organisations and Healthcare Professionals.

2017 Report

 

 

Research & Development
such as clinical trials, clinical & research collaboration and research grants
£20,984,241
(65.4%)
HCP contribution to cost of events
such as registration fees, travel and accommodation
£931,451
(2.9%)
HCP fees for service and related expenses
such as speaker engagements, general consulting, travel and accommodation
£2,679,252
(8.4%)
HCO contribution to cost of events
such as sponsorship agreements, registration fees, travel and accommodation
£2,506,015
(7.8%)
HCO donations and grants
such as charitable contributions, education grants and studentships
£3,484,569
(10.9%)
HCO Joint Working £140,000
(0.4%)
HCO fees for service and related expenses
such as speaker engagements, general consulting and services, travel and accommodation
£1,339,901
(4.2%)
  Total £32,065,430

 

Visit www.disclosureuk.org.uk to see full database. If you would like to find out more about how we put the data together, you can view our Methological Note.

You can also view our HCO grants and donations report here.

[Data gathered 18 May 2018]

 

2016 Report

 

 

Research & Development
such as clinical trials, clinical & research collaboration and research grants
£32,158,963
(75.1%)
HCP contribution to cost of events
such as registration fees, travel and accommodation
£687,585
(1.6%)
HCP fees for service and related expenses
such as speaker engagements, general consulting, travel and accommodation
£2,597,467
(6.0%)
HCO contribution to cost of events
such as sponsorship agreements, registration fees, travel and accommodation
£1,640,822
(3.8%)
HCO donations and grants
such as charitable contributions, education grants and studentships
£3,852,334
(8.9%)
HCO Joint Working £219,353
(0.5%)
HCO fees for service and related expenses
such as speaker engagements, general consulting and services, travel and accommodation
£1,663,250
(3.8%)
  Total £42,819,775

 

Visit www.disclosureuk.org.uk to see full database. If you would like to find out more about how we put the data together, you can view our Methological Note.

You can also view our HCO grants and donations report here.

[Data gathered 30 August 2017]

 

2015 Report

 

 

Research & Development
such as clinical trials, clinical & research collaboration and research grants
£20,632,508
(71.7%)
HCP contribution to cost of events
such as registration fees, travel and accommodation
£600,886
(2.1%)
HCP fees for service and related expenses
such as speaker engagements, general consulting, travel and accommodation
£1,908,099
(6.6%)
HCO contribution to cost of events
such as sponsorship agreements, registration fees, travel and accommodation
£1,857,985
(6.5%)
HCO donations and grants
such as charitable contributions, education grants and studentships
£2,463,710
(8.6%)
HCO Joint Working £46,089
(0.2%)
HCO fees for service and related expenses
such as speaker engagements, general consulting and services, travel and accommodation
£1,283,744
(4.5%)
  Total £28,793,021

 

Visit www.disclosureuk.org.uk to see full database. 

You can also view our HCO grants and donations report here.

[Data gathered 30 August 2017]

Key Terms
"Fees for service/consultancy"

Refers to activities where healthcare professionals provide us with a service that we pay them for – such as speaking at meetings, chairing meetings, participating in advisory boards and providing other consultancy time. An example of other consultancy would be when Pfizer works with a healthcare professional as a consultant to advise on an issue such as medicine development, the role of a medicine in a patient pathway, health economics or best clinical practice.

Collaborations between healthcare professionals and the pharmaceutical industry are essential to gaining the real-world information necessary to develop and deliver innovative treatment choices that improve the health and wellbeing of patients, and to support research and development. These relationships also help the flow of information between industry and the NHS. As an integral part of the medicines development process it is appropriate that healthcare professionals are fairly compensated for their time and expertise.

 

"Sponsorship to attend third party medical education meetings"

Pfizer only supports registration fees to 3rd party medical education meetings up to an amount of £750 irrespective of whether the meeting is in the UK, Europe or outside Europe. From 2016, no partial contributions have been made to support attendance at third party meeting unless specifically requested by an HCP, for example, when they have already secured partial sponsorship elsewhere.

PP-PFE-GBR-1251 / June 2018